Eloxx Pharmaceuticals, Inc. insider trading

ELOXNASDAQ

$15.51-0.20 (-1.27%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Jun 9, 2026 to Oct 2, 2026. Price (+40.9%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21

Unlock quarterly net flow

Key players

SASumit AggarwalPresident and CEO41.4412%of company
DRDomicilium Real Estate Fund III LP10% Owner9.3117%of company
LALindsay AndroskiDirector0.3902%of company
AEAlan Edmund WaltsDirector0.3857%of company
SDSteven D. RubinDirector0.3623%of company
CCCoastlands Capital LP10% Owner0.00%of company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
No qualifying insider activity was found for the selected filters.

End of history · 0 transactions